what do glp 1 agonists do glp-1_analogs [TUSOM GLP-1 Agonists in Cardiovascular Diseases:

4 Other GLP-1RA approved by the US FDA for the treatment of T2DM include liraglutide (Victoza, 2010), exenatide extended-release (Bydureon, 2012), albiglutide (Tanzeum, 2014), and dulaglutide (Trulicity, 2014)

13 The median expected protection we determined for GLP-1 receptor agonistswhich exceeds 18 yearsis the highest yet reported for drug-device combinations

If you have a history of weight cycling, consider this when planning your GLP-1 treatment duration

GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients

Additionally, older GLP-1 drugs, such as exenatide, have seen a decline in claims since the early 2010s as newer drugs were introduced

There was a decrease in inflammatory monocyte population and tendency for differentiation towards M2 macrophages following liraglutide treatment, which was in line with previous findings